Search Results 2791-2800 of 17709 for rheumatoid arthritis

  1. Deb Balzer | Mayo Clinic News Network - Page 8 of 68

    Sometimes, this can lead to arthritis, causing pain in areas like the knees and hips. Dr. Rafael Sierra, a Mayo[...] By Deb Balzer • October 31, 2023. Mayo ...

  2. Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) - Mayo Clinic

    ... factor X inhibitors are permitted. NOTE: Warfarin may not be started while enrolled in the EAY131 study; Stopping the anticoagulation for biopsy should be per ...

  3. Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC - Mayo Clinic

    Transfusion and/or use of hematopoietic factor therapies are not permitted within 14 days prior to date of screening laboratory tests unless clinically ...

  4. Study to Treat Deadly Form of Thyroid Cancer Shows Promise, Mayo Clinic Says

    PPAR-gamma is a transcriptional factor that increases the expression of many genes, and Dr. Copland's early work on the agent showed that it forces PPAR ...

  5. Dr. Guojun Bu Archives - Mayo Clinic News Network

    increasingly more impaired, starving brain cells. “This study has furthered our understanding of the gene that's the strongest genetic risk factor known for ...

  6. A Study Assessing Robotic Surgery in the Seated Position for Benign and Malignant Lesions of the Head and Neck Using the da Vinci Robotic Surgical System - Mayo Clinic

    One major risk factor of the sitting position for neurosurgery is air embolism, especially in patients with persistent foramen ovale (PFO). The first aim of ...

  7. Mayo Clinic Minute: Bone marrow transplants for autoimmune disorders

    Learn how patients with autoimmune disorders, including Crohn's disease, may benefit from an autologous bone marrow transplant.

  8. Publications - Teresa A. Seville, M.D. - Mayo Clinic

    Rhodococcus erythropolis septic arthritis. BMJ Case Rep. 2023 Oct 6; 16 (10) Epub 2023 Oct 06. View PubMed; Yetmar ZA, Chesdachai S, Khodadadi RB, McHugh JW ...

  9. Esophageal Cancer Clinical Trials

    ... factor receptor 2 (HER2)+ gastrointestinal cancers. A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors ...

  10. Clinical trials - Oncology (Medical)

    For example, inflammatory bowel disease is a major predisposing factor for colorectal cancer occurrence, implicating inflammation in the development of ...